GAL-3 (Lok et al., 2010, 2013; De Boer et al., 2011; Ho et al., 2012; Lopez-Andrés et al., 2012) and ST2 (Pascual-Figal et al., 2009; Manzano-Fernandez et al., 2011) have been shown to have predictive value for adverse cardiac events and mortality especially in patients with heart failure and ST2 also in patients after acute coronary syndrome (Eggers et al., 2010). This evidence concerns the gene LGALS3 and acute coronary syndrome.